RASSF1 and non-small cell lung carcinoma: Similarly, the decreased number of cells in the G0/G1 phase (P < 0.01, Figure 7D) inhibited the apoptosis rate (P < 0.01, Figure 8A) and enhanced the cell invasive capacity associated with NSCLC (P < 0.01, Figure 8B), which were all induced by si‐circ_0078767 and were abrogated due to co‐transfection with miR‐330‐3p inhibitor or RASSF1A vector.